References
- Katsinelos P, Kountouras J, Paroutoglou G, Zavos C. Alopecia areata, primary sclerosing cholangitis and ulcerative colitis: An autoimmunity and apoptosis as common links? Dig Dis Sci. 2007;52(5):1288–1292.
- Shih DQ, Targan SR. Immunopathogenesis of inflammatory bowel disease. World J Gastroenterol. 2008;14(3):390–400.
- Humbert P, Dupond JL. The multiple autoimmune syndromes. Br J Dermatol. 1997;136:468–469.
- Snook JA, de Silva HJ, Jewell DP. The association of autoimmune disorders with inflammatory bowel disease. Q J Med. 1989;72(269):835–840.
- Namazi MR. Neurogenic dysregulation, oxidative stress, autoimmunity and melanocytorrhagy in vitiligo: Can they be interconnected? Pigment Cell Res. 2007;20(5):360–363.
- Khan R, Satyam A, Gupta S, Sharma VK, Sharma A. Circulatory levels of antioxidants and lipid peroxidation in Indian patients with generalized and localized vitiligo. Arch Dermatol Res. 2009;301(10):731–737.
- Dell'Anna ML, Mastofrancesco A, Sala R, Venturini M, Ottaviani M, Vidolin AP, Antioxidants and narrow band-UVB in the treatment of vitiligo: A double-blind placebo controlled trial. Clin Exp Dermatol. 2007;32(6):631–636.
- Salmon JF, Wright JP, Murray AD. Ocular inflammation in Crohn's disease. Ophthalmology. 1991;98:480–484.
- Rashidi T, Mahd AA. Treatment of persistent alopecia areata with sulfasalazine. Int J Dermatol. 2008;47(8):850–852.
- Ardizzone S, Bianchi Porro G. Comparative tolerability of therapies for ulcerative colitis. Drug Saf. 2002;25:561–582.
- Etchever MJ, Aceituno M, Sans M. Are we giving azathioprine too late? The case for early immunomodulation in inflammatory bowel disease. World J Gastroenterol. 2008;14(36):5512–5518.
- Bastida G, Nos P, Aguas M, Beltran B, Rubin A, Dasi F, Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2005;22(9):775–782.
- Masaaki K, Masatoshi S, Nihal SA. Antioxidant system and erythrocyte-life-span in mammals. Comp Biochem Physiol. 1993;106B:477–487.
- Baert F, Vermeire S, Noman M, Van Assche G, D'Haens G, Rutgeerts P. Management of ulcerative colitis and Crohn's disease. Acta Clin Belg. 2004;59(5):304–314.
- Domenech E. Inflammatory bowel disease: Current therapeutic options. Digestion. 2006;73(suppl 1):67–76. Epub 2006 Feb 8.
- Regueiro M, Valentine J, Plevy S, Fleisher MR, Lichtenstein GR. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. Am J Gastroenterol. 2003;98:1821–1826.